Bushman Julie L 4
4 · BIO-TECHNE Corp · Filed Oct 31, 2022
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Bushman Julie L
Director
Transactions
- Award
Common Stock
2022-10-27+338→ 1,012 total - Award
Stock Options (Right to Buy)
2022-10-27+865→ 865 totalExercise: $295.77Exp: 2032-10-27→ Common Stock (865 underlying)
Holdings
- 1,507
Stock Options (Right to Buy)
Exercise: $255.69From: 2021-10-28Exp: 2030-10-29→ Common Stock (1,507 underlying) - 361
Stock Options (Right to Buy)
Exercise: $278.87From: 2021-10-29Exp: 2030-07-31→ Common Stock (361 underlying) - 633
Stock Options (Right to Buy)
Exercise: $515.24From: 2022-10-27Exp: 2031-10-28→ Common Stock (633 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.